Molecular Pharmaceutics & Organic Process Research are scholarly journals that are respected for the research and information provided on the subject they cover. These scholarly journals written by and for people who have experience in a discipline or field. Research is often refereed, which means that it is reviewed by other researchers who are familiar with the subject of the article. OMICS International with its open access journals represents research results and progress in various scientific and medical disciplines. The OMICS group's Molecular Pharmaceutics & Organic Process Research is Scholarly, an open access journal that strives to publish quarterly issues and is keen to publish new discoveries related to the field of molecular pharmacology research and organic processes.
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Review Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Research Article: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Scientific Tracks Abstracts: Journal of Pharmacognosy & Natural Products
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Keynote: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report